Page 105 - பல்கலைக்கழகம் ஆஃப் வாஷிங்டன் பள்ளி மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail Credit: University of Cincinnati PORTLAND, OR - A first-of-its-kind randomized clinical trial found that patients with pancreatic cancer didn t live any longer than expected after receiving pre-operative chemotherapy from either of the two standard regimens, according to trial results published in JAMA Oncology. While the trial findings did not show a direct patient benefit, they do show that it s possible to safely administer chemotherapy prior to pancreatic cancer surgery. They also pave the way for better treatment testing for this notorious killer. With no symptoms in the early stages, and few effective therapies, pancreatic cancer is the fourth-most deadly cancer type in the United States. According to the American Cancer Society, only 20 percent of pancreatic cancer patients are alive one year after diagnosis. After five years, only about 7 percent are alive.

United statesAndrewm lowyHowards hochsterDavendra sohalJames lloyd wadeAndrea wang gillamKatherinea guthrieNamita gandhiMai duongPhilip agopSyed ahmadE gabriela chioreanUniversity of cincinnati cancer centerNational cancer instituteRutgers cancer institute of new jerseyData management center